Effect of estrogen and its antagonist on the expression of arginine vasotocin (AVT) and its oxytocic-like receptor VT3 in the shell gland of Japanese quail, Coturnix coturnix japonica.
Avian neurohypophysial hormone arginine vasotocin (AVT) is known to regulate shell gland contractility during oviposition. While studying the role of estrogen in the expression and regulation of AVT and its oxytocic-like receptor VT3, using in situ hybridization and immunohistochemistry, it was observed that the expression of AVT and its receptor was not detected in the shell gland of sexually immature Japanese quail. However, administration of estrogen to these birds not only stimulates the growth and activity (as assessed by increased mucosal fold length, total protein content and alkaline phosphatase level) of the shell gland but also upregulates the expression of AVT and VT3. Further, administration of estrogen antagonist tamoxifen to sexually mature bird shows opposite results. On the other hand, localization of ir-AVT, observed in the ovary of sexually mature bird, was not detected in the estrogen treated sexually immature quail. It is concluded that estrogen not only affects the growth and differentiation of avian oviduct, but also regulates the expression of shell gland AVT and its receptor VT3. Present findings suggest that the locally synthesized AVT acts in a paracrine way to upregulate VT3 receptor and thus facilitates the endocrine function of neurohypophysial AVT during oviposition.
Srivastava
Rashmi
R
Department of Zoology, Banaras Hindu University, Varanasi, 221005, India.
Cornett
Lawrence E
LE
Chaturvedi
Chandra Mohini
CM
D000818:Animals; D003370:Coturnix / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D020847:Estrogen Receptor Modulators / Q000494:pharmacology*; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D005836:Genitalia, Female / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D017483:Receptors, Vasopressin / Q000235:genetics* / Q000378:metabolism*; D012741:Sexual Maturation; D013629:Tamoxifen / Q000494:pharmacology; D014668:Vasotocin / Q000235:genetics* / Q000378:metabolism*
D020847:Estrogen Receptor Modulators; D017483:Receptors, Vasopressin; C034862:vasotocin receptor; D013629:Tamoxifen; C074283:estradiol 3-benzoate; D004958:Estradiol; D014668:Vasotocin